Herbas VPB

Print
EN | LT
LT - USE OF AN FGF-21 COMPOUND AND A GLP-1 COMPOUND FOR THE TREATMENT OF OBESITY
EN - USE OF AN FGF-21 COMPOUND AND A GLP-1 COMPOUND FOR THE TREATMENT OF OBESITY

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/18
A61K 38/26
A61P 3/04
European patent
(11) Number of the document 2185178
(13) Kind of document T
(96) European patent application number 08796800.4
Date of filing the European patent application 2008-07-30
(97) Date of publication of the European application 2010-05-19
(45) Date of publication and mention of the grant of the patent 2017-08-23
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2008/071508
Date 2008-07-30
PCT application publication
(87) Number WO 2009/020802
Date 2009-02-12
Priority applications
(30) Number Date Country code
953785 P 2007-08-03 US
Inventors
(72)
COSKUN, Tamer, US
GLAESNER, Wolfgang, US
Grantee
(73) ELI LILLY AND COMPANY, Lilly Corporate Center, Indianapolis, IN 46285, US
Title
(54) USE OF AN FGF-21 COMPOUND AND A GLP-1 COMPOUND FOR THE TREATMENT OF OBESITY
  USE OF AN FGF-21 COMPOUND AND A GLP-1 COMPOUND FOR THE TREATMENT OF OBESITY
Last update date 2021-04-30